Literature DB >> 14676056

Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment.

David F Tang-Wai1, David S Knopman, Yonas E Geda, Steven D Edland, Glenn E Smith, Robert J Ivnik, Eric G Tangalos, Bradley F Boeve, Ronald C Petersen.   

Abstract

BACKGROUND: The Mini-Mental State Examination (MMSE) is the most widely used brief screening measure of cognition, but it is not sensitive in detecting mild memory or other cognitive impairments. The Short Test of Mental Status (STMS) was specifically developed for use in dementia assessment and was intended to be more sensitive to problems of learning and mental agility that may be seen in mild cognitive impairment (MCI).
OBJECTIVE: To compare the STMS and MMSE for detecting or predicting MCI.
DESIGN: Comparison of STMS and MMSE scores at baseline among 4 groups of patients: 788 patients with stable normal cognition, 75 patients with normal cognition at baseline but who developed incident MCI or Alzheimer disease during follow-up, 129 patients with prevalent MCI at baseline, and 235 patients with prevalent mild Alzheimer disease. All patients and control subjects for this study were evaluated through the Mayo Alzheimer's Disease Patient Registry or the Mayo Clinic Alzheimer's Disease Research Center, Rochester, Minn, using a standardized diagnostic approach.
RESULTS: The STMS was slightly more sensitive than the MMSE in discriminating between patients with stable normal cognition and patients with prevalent MCI. The STMS was superior to the MMSE in detecting deficits in cognition in individuals who had normal cognition at baseline but later developed incident MCI or Alzheimer disease.
CONCLUSIONS: Compared with the MMSE, the STMS was better able to document MCI and was more sensitive in detecting deficits in cognition in individuals who had normal cognition at baseline but later developed incident MCI or Alzheimer disease.

Entities:  

Mesh:

Year:  2003        PMID: 14676056     DOI: 10.1001/archneur.60.12.1777

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  47 in total

1.  Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.

Authors:  Clifford R Jack; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Val Lowe; Kejal Kantarci; Matt A Bernstein; Matthew L Senjem; Jeffrey L Gunter; Bradley F Boeve; John Q Trojanowski; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; David S Knopman
Journal:  Arch Neurol       Date:  2012-07

Review 2.  Mild cognitive impairment in older adults.

Authors:  Yonas E Geda
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

3.  Screening for Early Alzheimer's Disease: Is There Still a Role for the Mini-Mental State Examination?

Authors:  Aaron D Benson; Melissa J Slavin; Thanh-Thu Tran; Jeffrey R Petrella; P Murali Doraiswamy
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

4.  Anatomic correlates of stereotypies in frontotemporal lobar degeneration.

Authors:  Keith A Josephs; Jennifer L Whitwell; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2007-06-14       Impact factor: 4.673

5.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

Review 6.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

7.  Language networks associated with computerized semantic indices.

Authors:  Serguei V S Pakhomov; David T Jones; David S Knopman
Journal:  Neuroimage       Date:  2014-10-12       Impact factor: 6.556

8.  Influence of mild cognitive impairment on activities of daily living in patients with cardiovascular disease.

Authors:  Kodai Ishihara; Kazuhiro P Izawa; Masahiro Kitamura; Takayuki Shimogai; Yuji Kanejima; Tomoyuki Morisawa; Ikki Shimizu
Journal:  Heart Vessels       Date:  2019-05-21       Impact factor: 2.037

9.  Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Authors:  Burcu Zeydan; Val J Lowe; Christopher G Schwarz; Scott A Przybelski; Nirubol Tosakulwong; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Rosebud O Roberts; Michelle M Mielke; Eduardo E Benarroch; Moses Rodriguez; Mary M Machulda; Timothy G Lesnick; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci; Orhun H Kantarci
Journal:  Mult Scler       Date:  2017-05-05       Impact factor: 6.312

Review 10.  Brief Cognitive Tests in the Case of Dementia and Alzheimer's Disease Early Diagnosis.

Authors:  Maria Sagiadinou; Antonia Plerou
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.